3 Apr 20251cites
Preclinical therapeutics for sickle cell disease: modern developments and future considerationsPublisher siteExpert Opinion on Investigational Drugs, Hemoglobinopathies and Related Disorders
Active, last published 2026
In hemoglobinopathies and related disorders
Iheanyi
Okpala
Scholar“Research focused on Hemoglobinopathies and Related Disorders and adjacent fields.”
Claim Your Profile21
H-index
1.8k
Citations
Iheanyi has not officially claimed their profile. If you are Iheanyi, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
heanyi Okpala is a researcher working on Hemoglobinopathies and Related Disorders. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Iheanyi's work has been cited 1,771 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Hemoglobinopathies and Related Disorders×66Iron Metabolism and Disorders×28Blood groups and transfusion×16Bone and Joint Diseases×12Acute Myeloid Leukemia Research×6
04 · Where I am
Affiliations
Affiliation on published researchUniversity of Nigeria Teaching Hospital, NigeriaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works6 Jan 2024Open access3cites
Antiviral response and HIV-1 inhibition in sickle cell diseasePublisher siteiScience, Hemoglobinopathies and Related Disorders
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Iheanyi?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you